190 related articles for article (PubMed ID: 31554354)
1. Modified Liquid-Based Cytology Technique for Immunocytochemistry in Effusion Specimen.
Patarapadungkit N; Jangsiriwitayakorn P; Chaiwiriyakul S; Sirivech P; Thongbor R; Phanomsri EO; Nititarakul L
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2611-2617. PubMed ID: 31554354
[TBL] [Abstract][Full Text] [Related]
2. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
Su XY; Li GD; Liu WP; Xie B; Jiang YH
Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
[TBL] [Abstract][Full Text] [Related]
3. New diagnostic technique for rapid fluorescence immunocytochemical staining of adenocarcinoma and mesothelial cells using liquid-based cytology.
Morimoto A; Ito A; Hashimoto K; Nakano A; Nagasaka T; Yokoi T
Acta Cytol; 2014; 58(5):461-8. PubMed ID: 25358455
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of a Limited Immuno-panel of Calretinin and Ber-EP4 for Diagnosis of Malignant Effusions.
Khurram N; Anis T; Yusuf NW
J Coll Physicians Surg Pak; 2019 Jan; 29(1):33-36. PubMed ID: 30630566
[TBL] [Abstract][Full Text] [Related]
5. Ber-EP4 staining in effusion cytology: A potential source of false positives.
Díaz Del Arco C; Saiz-Pardo Sanz M; Ortega Medina L; Fernández Aceñero MJ
Rev Esp Patol; 2021; 54(2):114-122. PubMed ID: 33726887
[TBL] [Abstract][Full Text] [Related]
6. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
[TBL] [Abstract][Full Text] [Related]
7. The application of immunocytochemistry to direct smears in the diagnosis of effusions.
Knoepp SM; Placido J; Fields KL; Thomas D; Roh MH
Diagn Cytopathol; 2013 May; 41(5):425-30. PubMed ID: 22549950
[TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of Modified Liquid-Based Cytology and CytoRich Red Preparation in Assessment of Serous Effusion for Cancer Diagnosis.
Jangsiriwitayakorn P; Patarapadungkit N; Chaiwiriyakul S; Thongbor R; Sirivech P; Nititarakul L
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1571-1575. PubMed ID: 29936781
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.
Hyun TS; Barnes M; Tabatabai ZL
Acta Cytol; 2012; 56(5):527-32. PubMed ID: 23075894
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
[TBL] [Abstract][Full Text] [Related]
11. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology.
Ang PP; Tan GC; Karim N; Wong YP
Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449
[TBL] [Abstract][Full Text] [Related]
13. The role of immunohistochemistry in the diagnosis of neoplastic pleural effusions.
Dinu M; Ciurea RN; Stefan M; Georgescu AC
Rom J Morphol Embryol; 2012; 53(3 Suppl):817-20. PubMed ID: 23188446
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions.
He DN; Zhu HS; Zhang KH; Jin WJ; Zhu WM; Li N; Li JS
World J Gastroenterol; 2004 Aug; 10(16):2406-8. PubMed ID: 15285029
[TBL] [Abstract][Full Text] [Related]
15. Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4, MCA-b-12 and EMA.
Stoop JA; Hendriks JG; Berends D
Cytopathology; 1992; 3(5):297-302. PubMed ID: 1288655
[TBL] [Abstract][Full Text] [Related]
16. EZH2, a unique marker of malignancy in effusion cytology.
Jiang H; Gupta R; Somma J
Diagn Cytopathol; 2014 Feb; 42(2):111-6. PubMed ID: 23636867
[TBL] [Abstract][Full Text] [Related]
17. Utility of a limited panel of calretinin and Ber-EP4 immunocytochemistry on cytospin preparation of serous effusions: A cost-effective measure in resource-limited settings.
Arora R; Agarwal S; Mathur SR; Verma K; Iyer VK; Aron M
Cytojournal; 2011; 8():14. PubMed ID: 21829416
[TBL] [Abstract][Full Text] [Related]
18. Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions.
Delahaye M; van der Ham F; van der Kwast TH
Diagn Cytopathol; 1997 Aug; 17(2):115-20. PubMed ID: 9258618
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology.
Oda T; Ogata S; Kawaguchi S; Minabe S; Dokyu M; Takahashi H; Kumazawa F; Shimazaki H; Takano M; Hase K; Ozeki Y; Kanoh S; Nakanishi K
Diagn Cytopathol; 2016 Jun; 44(6):499-504. PubMed ID: 27015745
[TBL] [Abstract][Full Text] [Related]
20. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]